维普中文期刊产品整合服务
10篇 您的检索式:作者名="One Es"
    题名 作者 年代 出处 被引量
1Plasma transforming growth factor β1 as a biochemical marker to predict the persistence of atrial fi- brillation after the surgical maze procedure 显示文摘On YK Jean ES Lee SY 2009J Thorac Cardio- vasc Surg2009,137,6:1
2Neurochemical, electrophysiological and immunocytochemical evidence for a noradrenergic link between the sympathetic nervous system and thymocytes显示文摘Vizi ES Orso E Osipenko ON 1995Neuroscience1995,168,:1
3Chronocuhural sorting of archaeological bronze objects using laser-induced breakdown spectrometry 显示文摘FORTES F J CORT'ES M SIM'ON M D 2005Analytica Chimica Acta2005,554,12:1
4Guidelines for Diagnosis and Treatment of Moyamo- ya Disease (spontaneous occlusion of the circle of Willis) 显示文摘Research Committee on the Pathology and Treatment of Spon- taneous occlusion of the Circle of Willis Health Labour Scienc- es Research Grant for Research on Measures for Infractahle Diseases 2012Neurol Med Chir (Tokyo)2012,52,5:1
5Guidelines for the management of aneurysmal suharachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/american Stroke Association 显示文摘CormoUy ES Jr Rabinstein AA Carhuapoma JR American Heart Association Stroke Council Council on Cardiovascular Radiology and Intervention Council on Cardiovascular Nursing Council on Cardiovascular Surgery and Anesthesia Council on Clinical Cardiology 2012Stroke2012,43,6:1
6Endovascular treatment in anterior circulation stroke beyond 6.5 hours after onset or time last seen well:results from the MR CLEAN Registry显示文摘Background Randomised controlled trials with perfusion selection have shown benefit of endovascular treatment(EVT)for ischaemic stroke between 6 and 24 hours after symptom onset or time last seen well.However,outcomes after EVT in these late window patients without perfusion imaging are largely unknown.We assessed their characteristics and outcomes in routine clinical practice.Methods The Multicenter Randomized Clinical Trial of Endovascular Treatment for Acute Ischemic Stroke in the Netherlands Registry,a prospective,multicentre study in the Netherlands,included patients with an anterior circulation occlusion who underwent EVT between 2014 and 2017.CT perfusion was no standard imaging modality.We used adjusted ordinal logistic regression analysis to compare patients treated within versus beyond 6.5 hours after propensity score matching on age,prestroke modified Rankin Scale(mRS),National Institutes of Health Stroke Scale,Alberta Stroke Programme Early CT Score(ASPECTS),collateral status,location of occlusion and treatment with intravenous thrombolysis.Outcomes included 3-month mRS score,functional independence(defined as mRS 0-2),and death.Results Of 3264 patients who underwent EVT,106(3.2%)were treated beyond 6.5 hours(median 8.5,IQR 6.9-10.6),of whom 93(87.7%)had unknown time of stroke onset.CT perfusion was not performed in 87/106(80.2%)late window patients.Late window patients were younger(mean 67 vs 70 years,p<0.04)and had slightly lower ASPECTS(median 8 vs 9,p<0.01),but better collateral status(collateral score 2-3:68.3%vs 57.7%,p=0.03).No differences were observed in proportions of functional independence(43.3%vs 40.5%,p=0.57)or death(24.0%vs 28.9%,p=0.28).After matching,outcomes remained similar(adjusted common OR for 1 point improvement in mRS 1.04,95%CI 0.56 to 1.93).Conclusions Without the use of CT perfusion selection criteria,EVT in the 6.5-24-hour time window was not associated with poorer outcome in selected patients with favourable clinical and CT/CT angiography characteristics.randomised controlled trials with lenient inclusion criteria are needed to identify more patients who can benefit from EVT in the late window.Luuk Dekker Esmee Venema F Anne V Pirson Charles B L M Majoie Bart J Emmer Ivo G H Jansen Maxim J H L Mulder Robin Lemmens Robert-Jan B Goldhoorn Marieke J H Wermer Jelis Boiten Geert J LycklamaàNijeholt Yvo B W E M Roos Adriaan C G M van Es Hester F Lingsma Diederik W J Dippel Wim H van Zwam Robert J van Oostenbrugge Ido R van den Wijngaard on behalf of the MR CLEAN Registry investigators 2021Stroke & Vascular Neurology2021,6,4:1
7Plasma transforming growth factor betal as a biochemical marker to predict the persistence of atrial fibrillation after the surgical maze procedure显示文摘On YK Jeon ES Lee SY 2009Thorac Cardiovasc Surg2009,137,:1
8Plasma transforming growth factor beta1 as a biochemical marker to predict the persistence of atrial fibrillation after the surgical maze procedure显示文摘On YK Jeon ES Lee SY 0,,:1
9Guidelines for diagnosis and treatment of Moyamoya disease (Spontaneous ()celusion of tile Circle of Willis)显示文摘Research Committee on the Pathology and Treatment of Sponta- neous Occlusion of the Circle of Willis : Health Labour Sciences Research Grant for Research on Measure for Infractable diseas- es 2012Neurol Med Chit (Tokyo)2012,52,5:1
10Personal sampler for nitrogen dioxide, Amer显示文摘PALM ES E D GUNNIS ON A F DIMAT T IO J 0,,37:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费